Researchers examine 69 existing drugs for efficacy against COVID-19

A team of researchers from around the world have identified 69 different drugs and compounds, including FDA-approved agents, compounds in clinical trials and preclinical compounds, that they are examining for potential effectiveness in SARS-CoV-2 infection assays. “So far, no clinically available antiviral drugs have been developed for SARS-CoV, SARS-CoV-2 […]

Click here to view original web page at

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.